...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Expectations for the AGM?
4
Dec 06, 2020 12:17PM
4
Dec 06, 2020 03:13PM
6
Dec 08, 2020 05:51PM

I'd be opposed to a CVR deal.

Shadowy Shares: The Dark Side of Contingent Value Rights
Forbes, May 9, 2011.

"....CVRs can transfer much of the risk normally borne by acquirers to the shareholders in the target corporation...."

1
Dec 10, 2020 01:09PM
2
Dec 10, 2020 01:51PM
3
Dec 10, 2020 02:35PM
3
Dec 10, 2020 02:55PM
Share
New Message
Please login to post a reply